Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Clinical Pharmacology|October 22, 2010
Lack of a pharmacokinetic interaction between steady-state tipranavir/ritonavir and single-dose valacyclovir in healthy volunteersJohn P Sabo, Xiuyu Julie Cong, Michael-Friedrich Kraft, et al.Pathology|January 1, 1985
Primary malignant fibrous histiocytoma of the uterus--ultrastructural and immunocytochemical studies of two casesS T Chou, D Fortune, N A Beischer, et al.Journal of Clinical Pharmacology|August 14, 2010
Coadministration with lopinavir and ritonavir decreases exposure to BILR 355, a nonnucleoside reverse transcriptase inhibitor, in healthy volunteersFenglei Huang, Paul Scholl, David B Huang, et al.Basic & Clinical Pharmacology & Toxicology|October 28, 2010
Concomitant administration of BILR 355/r with emtricitabine/tenofovir disoproxil fumarate increases exposure to emtricitabine and tenofovir: a randomized, open-label, prospective studyFenglei Huang, Paul Scholl, David B Huang, et al.Journal of Clinical Pharmacy and Therapeutics|December 7, 2010
Evaluation of steady-state pharmacokinetic interactions between ritonavir-boosted BILR 355, a non-nucleoside reverse transcriptase inhibitor, and lamivudine/zidovudine in healthy subjectsF Huang, L Allen, D B Huang, et al.JMIR Research Protocols|November 15, 2024
Methodology for Biological Sample Collection, Processing, and Storage in the Newcastle 1000 Pregnancy Cohort: Protocol for a Longitudinal, Prospective Population-Based Study in AustraliaJoshua J Fisher, Tegan Grace, Nathan A Castles, et al.Clinical Pharmacology and Therapeutics|February 12, 2010
A phenotype-genotype approach to predicting CYP450 and P-glycoprotein drug interactions with the mixed inhibitor/inducer tipranavir/ritonavirJ B Dumond, M Vourvahis, N L Rezk, et al.Pageof 2